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The H-NS protein is a major component of the Escherichia coli nucleoid. Mutations in hns, the gene encoding
H-NS, have pleiotropic effects on the cell altering both the expression of a variety of unlinked genes and the
inversion rate of the DNA element containing the fimA promoter. We investigated the interaction between H-NS
and fimB, the gene encoding the bidirectional recombinase that catalyzes fimA promoter flipping. In b-
galactosidase assays, we found that fimB expression increased approximately fivefold in an hns2-tetR insertion
mutant. In gel mobility shift assays with purified H-NS, we have also shown that H-NS bound directly and
cooperatively to the fimB promoter region with greater affinity than for any other known H-NS-regulated gene.
Furthermore, this high-affinity interaction resulted in a promoter-specific inhibition of fimB transcription. The
addition of purified H-NS to an in vitro transcription system yielded a fivefold or greater reduction in
fimB-specific mRNA production. However, the marked increase in cellular FimB levels in the absence of H-NS
was not the primary cause of the mutant rapid inversion phenotype. These results are discussed in regard to
both H-NS as a transcriptional repressor of fimB expression and its role in regulating type 1 pilus promoter
inversion.
H-NS is an approximately 15.4-kDa nucleoid-associated
Escherichia coli protein involved in bacterial chromatin con-
densation (12, 49, 50). The hns gene is autoregulated (16, 54),
and its expression is induced three- to fourfold upon cold
shock (5, 30). The H-NS protein binds tightly to double-
stranded DNA (dsDNA) as a homodimer (15, 49). H-NS does
not bind DNA in a strict sequence-specific manner (46), yet it
preferentially binds curved DNA (43, 51, 57). Most impor-
tantly, H-NS is a global regulator of a variety of unrelated
genes in E. coli (2, 31, 58) as well as being involved in virulence
expression in pathogenic Shigella (35), Salmonella (21), and
enteroinvasive E. coli (7) strains. In most instances, such as
with proU (22, 36), the bgl operon (8, 22), and the pap locus
(20), mutations in hns cause derepressed gene expression.
However, H-NS also acts as a positive regulator for lrp (33) and
flagellum biosynthesis genes (3). Two prevailing models exist
to explain the role that H-NS plays in modulating gene expres-
sion. In the first, H-NS takes an active role by directly binding
to DNA and inhibiting transcription (55). In the other, H-NS
acts passively in a purely structural role by inducing changes in
DNA supercoiling or chromosomal topology (23, 25, 53).
Type 1 pilus expression is predominately controlled at the
transcriptional level by the inversion of a 314-bp DNA element
containing the promoter of fimA, the gene encoding the major
pilus structural subunit (1, 13). Piliation is subject to phase
variation whereby in the “ON” orientation, the promoter ini-
tiates transcription, FimA monomers are synthesized, assem-
bled, and translocated to the bacterial cell surface. Conversely,
when the promoter element is in the “OFF” orientation, fimA
transcription cannot occur and the bacteria are nonpiliated.
Two different hns mutations (hns-1 and hns2-tetR) each cause
a 100-fold increase in fimA promoter inversion without affect-
ing reporter plasmid superhelical density. This mutant pheno-
type is exhibited only at lower temperatures (30°C) in an hns-1
strain but is temperature independent (30 to 42°C) in an hns2-
tetR strain (28).
FimB and FimE have been shown both genetically and bio-
chemically to be the bi- and unidirectional invertases, respec-
tively (18, 37, 38), required for flipping the fim switch in the
chromosome. Strains exhibiting the rapid inversion phenotype
in hns mutant backgrounds lacked FimE. In these hns mutant
strains FimB is the only recombinase present. Therefore, it is
plausible that H-NS may act indirectly to alter fimA promoter
inversion rates by controlling fimB expression. If H-NS nor-
mally represses fimB transcription, then in the absence of H-
NS, fimB expression would increase. Elevated cellular FimB
levels could subsequently lead to an increase in FimB-driven
fimA promoter recombination events, resulting in rapid DNA
inversion. In this study, we show that H-NS regulates FimB
levels in the cell, but this regulation is not the sole cause for
increased DNA flipping observed in hns mutant allele back-
grounds. We also provide evidence that H-NS has an indepen-
dent relationship with fimB, avidly and directly binding to the
promoter region and inhibiting transcription.
MATERIALS AND METHODS
Bacterial strains, plasmids, phage, media, genetic techniques, and enzyme
assays. The bacterial strains, plasmids, and phage used in this study are listed in
Table 1. Media consisted of Luria-Bertani (LB) broth, LB agar, or MacConkey
agar (Difco, Detroit, Mich.). When used, antibiotics were added to a final
concentration of 100 mg (ampicillin), 20 mg (tetracycline), 40 mg (kanamycin), 50
mg (streptomycin), or 50 mg (spectinomycin) per ml of medium. Restriction and
other DNA-modifying enzymes were used as instructed by the manufacturers
(Gibco-BRL, Gaithersburg, Md., and New England Biolabs, Beverly, Mass.).
Generalized transductions using P1 vir were carried out as previously described
(39). b-Galactosidase assays were performed as described elsewhere (39) on
strains grown in minimal media.
RNase protection assays. Total RNA was isolated and RNase protection
assays were performed as described elsewhere (32). Plasmid pML22 (Table 1)
served as the template for in vitro-transcribed 32P-labeled hns antisense probe.
Labeled RNA-RNA hybridized duplexes were separated on nondenaturing poly-
acrylamide gels and quantitated with a PhosphorImager (model 425F; Molecular
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Dynamics, Sunnyvale, Calif.) and ImageQuant version 3.3 software (Molecular
Dynamics).
H-NS purification. H-NS was purified by the protocol of Dersch et al. (9).
Briefly, a large-scale E. coli culture harboring hns on a multicopy plasmid
(pTHK113) was grown at 37°C, centrifuged to harvest the cells, and broken via
a French pressure cell. The cell lysate was clarified by ultracentrifugation and
subjected to two differential precipitations with 40 and 60% ammonium sulfate.
The resulting sample was passed through a dsDNA-cellulose column, and H-NS
was eluted with a 500 mM NaCl buffer. Fractions were analyzed on sodium
dodecyl sulfate (SDS)–15% polyacrylamide gels stained with Coomassie brilliant
blue. Fractions containing H-NS were pooled, dialyzed, confirmed by Western
analysis, and stored in aliquots. Protein concentrations were measured with a
Bio-Rad Dc protein assay kit (Bio-Rad, Hercules, Calif.).
Gel mobility shift assays. DNA substrates were generated by PCR amplifica-
tion from pSH2 and column purified with Wizard PCR preps (Promega, Madi-
son, Wis.). Fragments encompassing the fimB promoter region and upstream
repeats are the same as those depicted in Fig. 5A. PCR primers were generated
from sequence determined by Schwan et al. (48) and GenBank accession no.
Z37500. A constant amount of DNA was added to various amounts of purified
H-NS lacking contaminating DNase in a binding buffer consisting of 40 mM
Tris-Cl (pH 8.0), 40 mM MgCl2, 100 mM KCl, and 10% glycerol. The reaction
mixtures were incubated for 20 min at room temperature, electrophoresed on a
1% agarose gel in 13 Tris-acetate-EDTA, and stained with ethidium bromide.
In vitro transcription assays. Plasmid pYANK1, which contains fimB under
the control of its own promoter and upstream repeats, was made by cloning a
2-kb SmaI V fragment from pHP45V into the unique ClaI site of fimB in
pFIMB14 (Table 1). Plasmid pTACB, which contains fimB under the transcrip-
tional control of the tac promoter, was generated by cloning a 190-bp fimB PCR
product from pYANK1 into the EcoRI-HindIII sites of pKK223-3 (Table 1). The
single-round in vitro transcription assays were performed basically as previously
described (55). Supercoiled DNA was column purified (Qiagen, Chatsworth,
Calif.) and incubated with various amounts of H-NS in a reaction mixture
containing 50 mM Tris-Cl (pH 7.4), 14 mM MgCl2, 100 mM KCl, 5 mM dithio-
threitol, and 40 mg of acetylated bovine serum albumin per ml. The reaction
mixture was preincubated for 20 min at 37°C before 25 U of RNase inhibitor
(Ambion, Austin, Tex.) and 2 U of E. coli RNA polymerase (Boehringer Mann-
heim, Indianapolis, Ind.) were added and then further incubated for 1 h at 37°C
to form a transcriptional open complex. RNA synthesis was initiated by adding
a mixture of nucleoside triphosphates (Gibco-BRL) and 20 mCi of [a-32P]UTP
(800 Ci/mmol; Amersham, Arlington Heights, Ill.), and the mixture was incu-
bated for another 3 min. Remaining DNA template was degraded by adding 2 U
of RNase-free DNase I (Ambion) and incubating the mixture for another 15 min
at 37°C. The reaction was stopped and cleaned by extraction with acid-phenol–
chloroform pH 4.7 (5:1; Ambion) and chloroform-isoamyl alcohol (5prime3
3prime, Boulder, Colo.). Transcripts were ethanol precipitated with 5 mg of yeast
RNA as a carrier (Ambion), dried, and resuspended in 20 ml of loading buffer
(95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol
FF). Samples were heated at 80°C for 3 to 5 min and run on 5% polyacryl-
amide–8 M urea denaturing gels in 13 Tris-borate-EDTA. The gels were sub-
sequently dried and exposed to a phosphorimaging screen. Transcripts were
detected and quantitated by a Molecular Dynamics Storm 860 PhosphorImager
and ImageQuant version 4.2 software (Molecular Dynamics).
Protein preparation and Western blotting. Strains were grown with the ap-
propriate antibiotics at 37°C overnight, centrifuged to harvest the cells, and
resuspended in 5 ml of sonication buffer (300 mM NaCl, 50 mM NaH2PO4 [pH
7.8]). Bacteria were treated with 1 mg of lysozyme per ml and sonicated on ice
to lyse. The sonicate was centrifuged, and soluble proteins in the supernatant
were concentrated through a Centricon-10 column as instructed by the manu-
facturer (Amicon, Beverly, Mass.). Protein concentrations were measured with a
Bio-Rad Dc protein assay kit. FimB extract, NEC26(pIB378), was a gift from
David Gally (18) and was used at a 1:100 dilution.
Protein lysates (500 mg of each) were solubilized and then electrophoresed on
a 10 to 20% denaturing gradient gel (Jule Biotechnologies Inc., New Haven,
Conn.) at 20 mA. Proteins were transferred to nitrocellulose (Schleicher &
Schuell, Keene, N.H.) in a Hoefer TE22 unit (Hoefer Scientific Instruments, San
Francisco, Calif.) overnight at 20 mA. The membrane was probed with FimB
antiserum provided by David Gally (47) and goat anti-rabbit immunoglobulin-
horseradish peroxidase secondary antibody conjugate (Sigma, St. Louis, Mo.).
The antigen-antibody complexes were detected with the SuperSignal chemilu-
minescent substrate (Pierce, Rockford, Ill.).
RESULTS
Effect of hns lesions on fimB expression. FimB and FimE are
recombinases that catalyze the inversion of the fimA promoter
TABLE 1. Bacteria, plasmids, and bacteriophage used
Strain, plasmid, or
phage Description Reference or source
Bacteria
AAE261A MG1655 DlacZYA fimB-lacZYA 4
AL88 Same as AAE261A except hns1 linked to tetR P1 transduction from THK60
AL90 Same as AAE261A except hns2-tetR P1 transduction from THK62
AL92 Same as AAE261A except hns-1 linked to tetR P1 transduction from THK64
AL106 Same as ORN185 except fimB-tetR P1 transduction from ORN203
THK30 Same as ORN185 except hns2-tetR 28
THK32 Same as THK63 except F(fimA9-lacZYA-kan) 28
THK38 thr-1 leuB thi-1 D(argF-lac)U169 malA1 xyl-7 ara-13 mtl-2 gal-6 rpsL fhuA2 supE44
hns1 linked to tetR
27
THK63 Same as THK38 except hns-1 linked to tetR 27
THK60 Same as THK38 except F(proU9-lacZYA-kan) 27
THK62 Same as THK60 except hns2-tetR 27
THK64 Same as THK60 except hns-1 linked to tetR 27
ORN185 Same as THK38 except F(fimA9-lacZYA-kan) Tets fimE (insertion sequence ele-
ment)
28
ORN203 Same as ORN185 except fimE1 hns-1 fimB-tet Gift from Paul Orndorff
NEC26 BL21(DE3) Dfim 18
Plasmids and phage
pGEM4Z Cloning vector with opposing T7 and SP6 promoters Promega
pKK223-3 Expression vector containing tac promoter Pharmacia Biotech
pUC19 Cloning vector Promega
pHP45V Vector containing V fragment (Smr Spcr) 45
pSH2 Contains entire fim operon 41
pTHK113 pBR322 hns1 28
pML22 pGEM4Z with 175-bp amplified hns fragment from pTHK113 This study (Fig. 2)
pIB378 pET11 fimB1 18
pFIMB14 pUC19 with 1.5-kb amplified fimB fragment from pSH2 This study (Table 3)
pYANK1 pFIMB14 with 2-kb SmaI fragment from pHP45V This study (Fig. 5)
pTACB pKK223-3 with 190-bp amplified fimB fragment from pYANK1 This study (Fig. 5)
P1 vir Laboratory collection
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in the chromosome (18, 29, 37, 38). In strains lacking fimE,
fimA promoter inversion is catalyzed solely by the bidirectional
FimB recombinase. We have shown that hns mutations in-
crease fimA promoter inversion 100-fold in fimE mutant
strains (28). The effect of an hns2-tetR mutation on inversion is
independent of temperature. However, the hns-1 mutation is
cold sensitive (28) and presents a mutant phenotype only at
30°C. It has been postulated (28, 40) that H-NS may affect
inversion rates indirectly by influencing fimB expression. To
determine whether H-NS alters fimB expression, we delivered
three hns alleles (hns1, hns-1, and hns2-tetR) via P1 transduc-
tions into a single-copy chromosomal fimB-lacZ fusion strain
(Table 1) and measured b-galactosidase activity (39) (Fig. 1).
At 30°C, fimB expression was fivefold higher in the hns2-tetR
insertion mutant than in the wild-type strain. Interestingly, the
promoter point mutation hns-1 had no effect on fimB-lacZ
(Fig. 1). We concluded that fimB expression was significantly
induced in the absence of H-NS.
The hns-1 mutation confers a reduction in mRNA levels
relative to the wild-type strain. The hns-1 mutant allele con-
tains a single T-to-G transversion in the 235 region of the hns
promoter (28). Since the mutation does not alter the hns cod-
ing sequence and its effect on inversion can be alleviated by
increasing the copy number of the hns-1 clone in trans (28), we
hypothesized that this point mutation bestowed a decreased
level of H-NS in the cell. To test this hypothesis, an RNA
antisense probe derived from pML22 was used to detect hns
mRNA transcripts from hns1 (THK38) and hns-1 (THK63)
background strains in RNase protection assays (Fig. 2). As
predicted, the hns-1 allele resulted in an approximately 50%
decrease in hns-specific mRNA levels compared to a wild-type
strain at 30°C. There is also a corresponding decrease in H-NS
protein made by a strain carrying this mutation (our unpub-
lished data).
H-NS directly binds the fimB promoter region. The effects of
the hns-1 and hns2-tetR lesions on fimB expression suggested
to us that H-NS may have a high-affinity binding capacity for
fimB. The hns-1 allele conferred 50% less hns mRNA and
subsequently less H-NS protein in the cell compared to wild-
type levels (Fig. 2). However, this large decrease in cellular
H-NS amounts had no effect on fimB expression. In b-galac-
tosidase assays, fimB was still basally expressed and not dere-
pressed in an hns-1 background (Fig. 1). One way this obser-
vation could be explained is if H-NS bound tightly to fimB.
High-affinity H-NS binding sites on fimB could compensate for
having one-half as much H-NS in the cell. Thus, at lowered
H-NS levels as exhibited in an hns-1 background, there would
still be enough protein to repress fimB expression because of
the tight binding between H-NS and fimB DNA. To study a
possible H-NS–fimB interaction, we investigated the binding of
purified H-NS to portions of the fimB promoter region in gel
mobility shift assays.
H-NS was purified to homogeneity (Fig. 3), and increasing
amounts were incubated separately with two contiguous DNA
fragments of the fimB promoter region. These fragments are
the same as those depicted in Fig. 5A. The fimB promoter is a
464-bp DNA segment encompassing the two putative promot-
ers and all sequence up to the translational start (ATG) (48).
The second piece of DNA is directly 59 of the promoters and
contains 457 bp including two sets of direct repeats, herein
termed upstream repeats (URs), implicated by Schwan et al. as
possible protein binding sites (48). Several conclusions can be
drawn from this binding assay (Fig. 4). First, H-NS bound to
both the UR region (lanes 5 to 7) and the fimB promoter
(lanes 11 to 14), as shown by slower-migrating complexes.
Second, in agreement with previous work (46), H-NS exhibited
FIG. 1. Effects of hns alleles on fimB expression. All strains containing a
fimB-lacZYA fusion and the indicated hns allele were grown to mid-log phase at
30°C and assayed for b-galactosidase activity (39). Data represent the averages of
three independent experiments, each done in triplicate.
FIG. 2. Comparison of hns mRNA levels. Total RNA isolated from THK38
(hns1) and THK63 (hns-1) grown at 30°C was hybridized to a 32P-labeled hns
antisense probe and separated on a nondenaturing polyacrylamide gel. Duplexes
were quantitated with a PhosphorImager.
FIG. 3. H-NS purification analysis. Samples were run on an SDS–15% poly-
acrylamide gel and stained with Coomassie brilliant blue. Lane 1, protein stan-
dards with sizes indicated to the left; lane 2, flowthrough that did not bind to the
dsDNA-cellulose column; lane 3, purified H-NS that was bound and eluted off of
the column, pooled, and dialyzed. Protein in lane 3 served as the source of
purified H-NS in all subsequent experiments in this study.
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a cooperative mode of binding to both substrates. This coop-
erative binding was exemplified when a less than twofold in-
crease in protein concentration changed the DNA substrate
profile from 100% free to mostly H-NS bound (compare lanes
4 and 5). Also, as more H-NS was added to subsequent lanes,
the protein-DNA complex became increasingly retarded within
the gel. The decrease in intensity of fluorescence between free
and bound DNA (compare lanes 4 and 5) was probably a
consequence of H-NS binding and obscuring ethidium bro-
mide intercalating sites on the DNA. A disappearance of vis-
ible free DNA without an equal intensity of complexed DNA
is a typical result in ethidium bromide-stained agarose gel
mobility shift assays (34, 53, 56).
However, there were also differences between H-NS binding
patterns with each substrate. In particular, H-NS showed a
higher affinity for the fimB promoter than for the URs by
binding at a lower concentration. The first signs of binding to
the fimB promoter occurred in lane 11 at a remarkably low
35:1 molar ratio of H-NS to DNA. Another interesting obser-
vation was that multiple shifted bands were visible within the
same lane (lanes 13 and 14) as the H-NS concentration was
increased. This ladder effect is usually indicative of multiple
specific binding sites on the DNA fragment. We concluded
from these experiments that (i) H-NS bound cooperatively and
directly to both the core fimB promoter region and upstream
AT-rich sequences, (ii) binding to the promoter may have been
tighter than binding to the URs, (iii) there were two possible
specific H-NS binding domains within the promoter region,
and (iv) this H-NS–fimB promoter interaction may result in
fimB repression.
H-NS represses transcription of fimB in vitro. We sought to
determine whether the direct binding of H-NS to a DNA
segment carrying the fimB promoter element and proximal
sequences had any effect on fimB expression. It is clear that the
ability to bind directly to or near the core region could enable
H-NS to repress fimB expression (6). To determine the role of
H-NS at the fimB promoter, we undertook an in vitro tran-
scriptional analysis with several different templates (Fig. 5A).
We used only circular supercoiled DNA plasmid templates in
an attempt to accurately reflect in vivo conditions and to ac-
count for the observation that some H-NS-regulated genes
have been proposed to be sensitive to changes in DNA topol-
ogy (10, 23–26, 53).
Plasmid pYANK1 was generated by cloning a 1.5-kb insert
containing the entire fimB coding sequence with its putative
promoters and upstream repeats into pUC19. A 2-kb V frag-
ment (45) which is flanked by inverted repeats with tran-
scriptional and translational termination signals was also
inserted into fimB to shorten fimB-specific transcript size and
minimize nonspecific vector-based transcripts. Thus, mRNA
from pYANK1 represents transcription of fimB under the con-
trol of its own promoter. Figure 5B shows the results of an in
vitro transcription assay with pYANK1 as the input DNA tem-
plate and increasing H-NS concentrations (0 to 585 pM). The
fold decreases in expression between individual reactions and
reactions with no H-NS added, as quantitated by a Phospho-
rImager, are summarized in Table 2. There are several salient
points to be made based on these data. The addition of 97.5
pM pure H-NS yielded the first modest but detectable and
reproducible 1.3-fold decrease in fimB transcription (lane 3).
At higher H-NS concentrations, this decrease dropped to ap-
proximately fivefold (lane 4), which represents an 80% inhibi-
tion of transcription. With the addition of even more H-NS,
fimB mRNA was virtually undetectable (lanes 5 and 6). It is
interesting that two transcripts were consistently observed
from pYANK1, and both were equally affected by H-NS. Their
estimated sizes of 350 (P1) and 490 (P2) nucleotides corre-
spond to fimB-specific mRNAs identified by previous primer
extension studies (48). These data clearly support the fact that
fimB contains two active promoters which are both transcrip-
tionally repressed by H-NS.
To assess the specificity of this H-NS-controlled transcrip-
tional inhibition of fimB, we performed a promoter swap. In
previous studies, it has been shown that the tac promoter is
relatively hns independent (55, 56). Thus, we cloned a 190-bp
fragment initiating from the fimB translational start (ATG)
into pKK223-3. In the resulting plasmid, pTACB (Fig. 5A),
fimB was under the transcriptional control of Ptac and vector
readthrough was blocked by the strong rrnB ribosomal termi-
nators (T1T2) downstream. In contrast to pYANK1, when fimB
FIG. 4. Gel mobility shift assays with H-NS and fragments of the fimB promoter region. H-NS–DNA complexes were electrophoresed on a 1% agarose gel and
stained with ethidium bromide. The left side of the gel represents complexes with the distal 59 UR region, and the right side represents binding to the fimB promoter.
Each lane contains a constant amount of DNA (0.67 pM for UR and 1.13 pM for fimB promoter) with increasing amounts of H-NS. Lanes 1 and 8, DNA only; lanes
2 and 9, 1.3 pM H-NS; lanes 3 and 10, 13 pM H-NS; lanes 4 and 11, 39 pM H-NS; lanes 5 and 12, 65 pM H-NS; lanes 6 and 13, 91 pM H-NS; lanes 7 and 14, 130 pM
H-NS. Free DNA and complexes are indicated by arrows; multiple shifted bands within a single lane are indicated by arrowheads with open circles.
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expression was driven by the tac promoter, transcription was
unaffected by H-NS until high concentrations were added (Fig.
5C, lanes 3 and 4). Even at the maximum amount of H-NS
added (390 pM), the fold reduction in fimB expression was
only 1.7 (Table 2). As a control, we also measured transcription
from the vector pKK223-3 alone. In addition to the tac pro-
moter, this vector contains the 5S rRNA gene, which was
transcriptionally unaffected by H-NS (Fig. 5C) as evidenced by
the minuscule reduction in transcription at the maximal H-NS
concentration (lane 8). We concluded from these experiments
(Fig. 5 and Table 2) that H-NS functions as a direct transcrip-
tional repressor of fimB expression specific for the natural fimB
promoter and/or upstream sequences.
Increased cellular FimB levels do not mimic the effect of an
hns mutation on inversion. Since fimB expression is increased
(reference 40 and this study) and fimA promoter inversion
rates are rapid in the absence of H-NS (28), it is possible that
the mechanism by which H-NS regulates fimA promoter inver-
sion is through altering FimB levels. To directly test this pos-
sibility, we added fimB in trans to a strain with a wild-type hns
background and assayed for the effect on inversion. In strains
carrying a fimA9-lacZYA-kan fusion, inversion is detectable
phenotypically on lactose MacConkey plates. In wild-type
strains, individual colonies are either red (Lac1) or white
(Lac2). These colors represent colony populations with the
fimA promoter orientation predominately ON or OFF, respec-
tively. However, colonies from hns mutant strains are uni-
formly pink, consisting of approximately equal numbers of
ON- and OFF-oriented individual cells (28). If H-NS is work-
ing solely through fimB expression to affect inversion rates,
then higher cellular FimB amounts should mirror an hns le-
sion, i.e., rapid fimA promoter inversion (pink colony pheno-
type).
We used pFIMB14 as a source of exogenous fimB (Table 1).
This plasmid is the parental clone of pYANK1 containing the
entire fimB coding, promoter, and upstream repeat sequences
but lacking the V fragment. This high-copy-number plasmid
carrying fimB complemented a fimB knockout strain (AL106)
and expressed a full-length protein product (data not shown),
thus ensuring its biological activity. To confirm that the addi-
tion of cloned fimB in trans did indeed lead to elevated FimB
levels in the cell, we performed a Western blot analysis on
equal amounts of cell lysates probed with FimB antiserum
(Fig. 6). AL106 served as an inactivated fimB negative control.
This mutant strain contains a tet cassette inserted into fimB. As
a positive control, we used a FimB extract which has previously
been demonstrated to possess FimB activity in vitro (18). It was
evident that when fimB was provided in trans to a wild-type
background strain, the amount of FimB in the cell substantially
increased (lane 4). FimB expression from the wild-type strain
alone (ORN185) was not detectable in this assay (lane 3). This
FIG. 5. In vitro transcription analysis. (A) Schematic diagram of promoter
fragments used in these experiments. Plasmid names are indicated to the left.
Transcripts with estimated sizes are indicated by wavy lines. (B) Phosphorimage
of a single-round in vitro transcription assay with pYANK1 and H-NS. Super-
coiled plasmid DNA (0.15 pM) was added to increasing amounts of H-NS. Lanes
1 to 6 contain 0, 48.75, 97.5, 195, 390, and 585 pM H-NS, respectively. fimB
transcripts from both promoters, P1 and P2, are indicated by arrows to the left.
(C) Phosphorimage of a single-round in vitro transcription assay with pTACB or
pKK223-3 and H-NS. Supercoiled plasmid template (0.15 pM each) was added
to increasing amounts of H-NS. Lanes 1 and 5, 0 pM H-NS; lanes 2 and 6, 97.5
pM H-NS; lanes 3 and 7, 195 pM H-NS; lanes 4 and 8, 390 pM H-NS. Transcripts
for each gene are indicated by arrows.
FIG. 6. Western blot of FimB expression. Lysates were run on an SDS–10 to
20% polyacrylamide gradient gel, transferred to nitrocellulose, and probed with
FimB antiserum (47). Lane 1, control FimB extract, NEC26(pIB378), diluted
1:100; lane 2, fimB knockout; lane 3, wild-type strain; lane 4, wild-type strain with
fimB clone in trans; lane 5, wild-type strain with vector alone in trans; lanes 2 to
5, 500 mg of protein lysates. Protein standard sizes are indicated by lines to the
left; full-length FimB is indicated by the arrow to the right.
TABLE 2. Quantitation of fimB and 5S mRNA transcriptional
repression depicted in Fig. 5B and C
Plasmid
Fold decrease in transcriptiona
with H-NS concn (pM) of:
97.5 195 390
pYANK1 1.3 5 TRb
pTACB 1 1.2 1.7
pKK223-3 1 1 1.2
a Determined by comparing transcript pixel volumes between reactions with
the indicated H-NS amounts and reactions with no H-NS. For example, a one-
fold decrease reflects no difference in pixel values, twofold represents a 50%
reduction, etc. Each number represents an average of three independent exper-
iments quantitated on a PhosphorImager.
b TR, total repression (no visible fimB mRNA).
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result was not surprising since FimB represents only 2 to 5% of
the total soluble protein in the cell (18).
When plated on indicator media, wild-type E. coli strain
ORN185 produced red and white colonies, whereas a rapid
inversion frequency represented by pink colonies was seen in
both hns lesion backgrounds (Table 3). When any of the ex-
perimental plasmids were transformed into the hns1 back-
ground strain (ORN185), there was no effect on inversion.
Thus, the addition of fimB in trans alone (pFIMB14) or in
combination with the entire fim operon (pSH2) did not cause
a detectable increase in fimA promoter inversion. We con-
cluded from these experiments that in a FimE-independent
inversion system, an excess of cellular FimB did not mimic the
effect of an hns mutation.
DISCUSSION
One of the many systems in which H-NS plays a regulatory
role is the expression of E. coli type 1 piliation. We have
previously shown that fimA promoter inversion frequencies are
increased 100-fold (28) in strains containing either an hns
promoter point (hns-1) or an insertion (hns2-tetR) mutation.
We envisage two ways H-NS may be acting to influence inver-
sion: (i) directly at the invertible element (IE) containing the
fimA promoter or (ii) indirectly through the gene for the bidi-
rectional recombinase, fimB (18, 29, 37, 38). In the first model,
wild-type levels of H-NS could bind to DNA sequences within
the IE, to sequences on either side of the IE, or to 9-bp
inverted repeats flanking the IE to hinder flipping or preclude
the binding of activators such as integration host factor (11, 14)
and Lrp (4, 19) or the recombinases (FimB and FimE). In the
latter model, H-NS may affect DNA inversion indirectly by
altering levels of FimB in the cell. Since FimB is the bidirec-
tional recombinase for the fim switch and the only recombinase
present in many strains, increased FimB could potentially in-
crease the chromosomal recombination events of the fimA
promoter. Addressing the indirect model, in this study we
showed that fimB expression increased over fivefold in a strain
lacking H-NS but was unaffected in a strain containing approx-
imately one-half the normal amount of the protein. The dis-
crepancy between our results and previous data reporting a
20-fold increase in fimB expression in an hns mutant strain (40)
is probably due to the fact that Olsen and Klemm (40) used a
plasmid-based system whereas our b-galactosidase assays were
performed with a more relevant, in vivo-like single-copy chro-
mosomally located fimB-lacZ fusion.
Two lines of evidence presented here suggest that this in-
crease in fimB expression was not the sole cause of the rapid-
inversion phenotype witnessed in an hns mutant background.
First, mimicking the loss of H-NS by supplying fimB exog-
enously on a plasmid in trans did not alter the normal inversion
phenotype. That is, excess FimB in the cell did not cause a
faster-flipping IE in a wild-type hns background. Second, an
hns lesion, hns-1, which causes a rapid switch rate (28) did not
affect fimB expression. Additionally, we have isolated hns point
mutations that dramatically increase fimB expression (up to
25-fold) but have no effect on inversion (unpublished data).
Thus, H-NS does not regulate inversion strictly through mod-
ulating the levels of the FimB recombinase.
Previously we characterized hns-1 as a promoter point mu-
tation (28). Since the H-NS protein produced by this mutant
allele is not altered, we hypothesized that the mutant pheno-
types observed in this strain were due to decreased hns mRNA
and subsequently decreased protein levels. Our RNase protec-
tion analysis confirmed that there was indeed a 50% decrease
in hns-1 mRNA levels relative to the wild-type hns allele at
30°C. Although this hns mutation confers less H-NS protein in
the cell, this reduced concentration did not affect fimB expres-
sion. This result suggested the possibility that H-NS had a
high-affinity binding capacity for fimB. If H-NS could bind
tightly to fimB regulatory regions, then one-half as much H-NS
present in an hns-1 strain could still conceivably repress tran-
scription. This observation is quite novel since it is the first
instance in which this hns-1 mutation did not mimic hns2-tetR
in regard to the derepression of gene expression. Both proU
and bgl are derepressed in the presence of either lesion, albeit
to different levels (27).
To study the H-NS–fimB interaction, we purified H-NS and
two separate fragments of the fimB promoter region and
showed that H-NS bound directly to both segments in gel
mobility shift assays. The purity of our H-NS preparation was
particularly important due to the nature of our purification
scheme involving a final dsDNA-cellulose column chromatog-
raphy step. Others have suggested that H-NS may act indirectly
by binding and stabilizing other protein-DNA interactions
(17). If this were the case at fimB, then other eluted DNA-
binding proteins would be prime candidates for directly bind-
ing fimB. However, due to the extreme purity of our H-NS
sample and the fact that we were able to detect H-NS in the
H-NS–fimB promoter complex (data not shown), we are con-
fident that all observed shifts in DNA mobility were due solely
to the presence of H-NS alone.
While analyzing the gel shifts, we were struck by a number of
interesting points. It was evident that H-NS bound both the
fimB promoter and the UR region (48) at concentrations that
did not shift a synthetic control noncurved DNA fragment
(data not shown). Binding appeared to be cooperative, as sug-
gested by Rimsky and Spassky (46), whereby a small change in
H-NS concentration led to a drastic difference in DNA mobil-
ity. This result suggests that H-NS may first bind tightly to
DNA and then form H-NS–H-NS interactions as protein con-
centrations are increased. Though the data are not definitive, it
also appeared that H-NS may bind to at least two separate sites
within the fimB promoter, as illustrated by multiple complexes
within one reaction lane. This binding pattern is similar to that
for the rrnB P1 promoter region, where H-NS has been shown
through several different footprinting techniques to interact
with three DNA domains (52). Most notable, though, were the
very low amounts of H-NS needed to first form a protein-DNA
complex. We needed only a 35:1 H-NS-to-DNA molar ratio to
shift the fimB promoter fragment. To the best of our knowl-
edge, this is the highest affinity binding capacity that H-NS has
exhibited for any DNA substrate yet. The H-NS affinity for
fimB is approximately 104- to 105-fold higher than the binding
of H-NS to proU or rrnB DNA (34, 52) and about 3- to 10-fold
higher than binding to an ideal synthetic curved substrate (56,
59). In the past, researchers have had to add exorbitant
TABLE 3. Effect of additional fimB in trans on fimA
promoter inversion
Strain Inversion phenotypea
ORN185 (hns1).................................................Red and white (normal)
THK30 (hns2-tetR)............................................Pink (rapid)
THK32b (hns-1) .................................................Pink (rapid)
ORN185(pUC19) ..............................................Red and white
ORN185(pFIMB14)..........................................Red and white
ORN185(pSH2).................................................Red and white
a All strains carry fimA9-lacZYA-kan fusions and were grown at 37°C on lac-
tose MacConkey indicator medium.
b THK32 was grown at 30°C due to the cold sensitivity of the hns-1 allele (28).
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amounts of H-NS in order to visualize a DNA-binding ability.
Here we demonstrate the specificity that H-NS has for the
fimB promoter region by the addition of very little protein.
Taking into account that H-NS acts as a dimer (15, 49), a 35:1
molar ratio of total H-NS to DNA may represent only a 17.5:1
ratio of functional H-NS to DNA.
Due to the tightness of the interaction between H-NS and
the fimB promoter sequences, we surmised that this interaction
was the cause of decreased fimB expression in wild-type cells.
Our in vitro transcription analyses confirmed the biological
effect that H-NS had on fimB: direct, promoter-specific repres-
sion. The negligible effect that H-NS had on a control plasmid,
pKK223-3, carrying the tac promoter but no fimB sequence
could be accounted for by the weak binding affinity that H-NS
has exhibited for Ptac at very high concentrations (52). Thus, at
a saturating amount of H-NS protein, it was not surprising that
there was a low level of 5S mRNA inhibition. A modest in-
crease in repression was quantitated when assays were done
with pTACB. The only difference between this plasmid and
pKK223-3 is the presence of 190 bp of fimB coding sequence.
It is possible, and not unprecedented, that H-NS binds down-
stream of the transcriptional start site and still affects transcrip-
tion. This has been demonstrated in the proU system of E. coli
and Salmonella typhimurium (34, 43), where H-NS binds within
proV, the first gene of the operon, and alters gene expression.
However, the greatest repression in our in vitro transcription
assays was observed when H-NS was added to pYANK1, a
supercoiled template harboring fimB under the control of its
natural promoter and upstream 59 repeat sequences. Since the
promoter sequences are the only difference between pYANK1
and pTACB, it is likely that H-NS requires the recognition and
binding of the fimB promoter in order to specifically repress
fimB transcription. This binding is the mode of operation of
H-NS in regard to rrnB P1 inhibition (52). In this system, H-NS
binds to three sites, one directly over the RNA polymerase
binding site and two upstream of the core region to block
transcription initiation. The apparent differences in H-NS/
DNA molar ratios needed to see an effect between the gel
mobility shift and in vitro transcription assays are probably due
to the nature of each assay. There are inherent differences in
procedure, sensitivity, buffers, and especially input template
DNA (linear versus supercoiled) between the two. It is also
reasonable that less protein may be needed to visualize an
initial binding to DNA than to exert an effect on transcription.
We envision two ways in which H-NS could alter fimB ex-
pression based on the in vitro studies. In the simpler model, the
high-capacity binding between H-NS and the core fimB pro-
moter may preclude RNA polymerase from binding and form-
ing an efficient transcription initiation complex. In an alternate
though not mutually exclusive model, the binding of H-NS
upstream of the promoter may aid in blocking transcription.
Many intrinsically curved sequences in the E. coli chromosome
are found upstream of promoters (51), and H-NS is known to
have an affinity for curved DNA (43, 57). Thus, H-NS may act
as a negative regulator by steric hindrance (44). By binding to
the UR, H-NS could bend the DNA in such a way as to change
the 210 and 235 spacing or disrupt the RNA polymerase-
DNA promoter interactions. In either case, H-NS is not acting
as a classical repressor since we do not believe that it recog-
nizes a specific consensus sequence. However, we also do not
think that H-NS binds randomly to fimB promoter sequences
to exert an effect. This is most evident in the necessity of
providing the fimB natural promoter rather than the tac pro-
moter in order to observe transcriptional repression. Instead, it
is possible that H-NS recognizes a specific DNA feature. This
feature could be a specific conformation such as an intrinsic
curvature or a stretch of AT base pairing. Tracts of AT base
pairing are abundant in the fimB promoter and UR regions
and has been implicated before (34) as a requirement for the
H-NS effect on gene expression. These concepts do not exclude
the role other factors, such as DNA topology, may play in
H-NS-mediated regulation.
Through combined in vitro and in vivo assays, we have iden-
tified a gene, fimB, in which H-NS acts as a promoter-specific
transcriptional repressor. Further work will continue to deter-
mine the affinity that H-NS has for the fimB promoter region,
to distinguish the exact domains necessary for repression, and
to determine whether H-NS acts to antagonize yet unidentified
activators of fimB expression.
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